Top 30 Medical Device Angel Investors in Israel
A list of 30 angel investors that invest in Medical device startups based in Israel. We rank investors based on the number of investments they made in Medical device companies from Israel. We update this investor list every month.Top 30 Medical Device Angel Investors in Israel
Investor | Medical Device Israel investments |
---|---|
Ron C | 2 |
Zohar Gilon | 2 |
Yehuda Zisapel | 2 |
Prof. Rafael Beyar | 2 |
Mazal CB | 2 |
Rafi Gidron | 1 |
Alan Patricof | 1 |
Marius Nacht | 1 |
Ran Tuttnauer | 1 |
Oren Dobronsky | 1 |
Moshe Yanai | 1 |
Danny Hadar | 1 |
Lewis Pell | 1 |
Jim Elkind | 1 |
Haim Chizic | 1 |
Amir Gross | 1 |
Benny Levin | 1 |
Avi Kornreich | 1 |
Moshe Gaon | 1 |
Jeremy Coller | 1 |
Shahar Tzafrir | 1 |
Dov Moran | 1 |
Jacques R. Seguin | 1 |
Zohar Zisapel | 1 |
Daniel Koss | 1 |
Shmuel Cabilly | 1 |
Ole T. Jensen | 1 |
Tzachi Arabov | 1 |
Rafi Benary | 1 |
Shimon Eckhouse | 1 |
Ron C
Show more
Investment focus
- Health Care, Therapeutics, Medical Device
- Seed, Pre-Seed
- Israel
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more
Investment focus
- Software, Internet, Health Care
- Seed, Series A, Series B
- Israel, United States
Portfolio highlights
- CADY — CADY leverages AI technology to automate the laborious task of inspecting electrical schematics, leading to a reduction in re-spins, faster Time to Market, and enhanced quality, reliability, and safety of the end product.
- Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
- Annabella — The only Breast Pump that simulates your baby's tongue to optimize milk output naturally and efficiently. Our Tongue Technology is known to stimulate milk-producing hormones.
Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.
Show more
Investment focus
- Medical Device, Medical, Health Care
- Funding Round, Series A, Seed
- Israel
Portfolio highlights
- Carteav — Our mission is to create and distribute autonomous low-speed vehicles (LSVs) that inspire mass-market adoption on a global scale.
- Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
- Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.
Prof. Rafael Beyar
Show more
Investment focus
- Medical, Medical Device, Machine Learning
- Seed, Series A
- Israel
Portfolio highlights
- MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
Mazal CB
Show more
Investment focus
- Health Care, Therapeutics, Medical Device
- Seed, Pre-Seed
- Israel
Portfolio highlights
- DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Rafi Gidron is the Chairman and Co-Founder of Xperiti. He attended Columbia University.
Show more
Investment focus
- Artificial Intelligence, Cyber Security, Financial Services
- Seed, Angel, Series B
- Israel, United States, United Kingdom
Portfolio highlights
- Blyp — Blyp is an AI-driven data analytics platform for e-commerce companies.
- Vyzer — One platform for investment tracking, financial planning, data-driven insights, document analysis & more! Ideal for diverse portfolios.
- GlossAI — GlossAI bridges the gap between the content created by organisations and how people consume it .Today's audiences do not have the attention span to listen to anything for an extended period of time. Even those attending events, podcasts, training sessions, and zoom calls can't keep up. At GlossAI we get smart AI video generator that canturn any single piece of content into many short videos, blog posts and more various channels and use cases.
Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.
Show more
Investment focus
- Financial Services, Finance, Health Care
- Series A, Seed, Funding Round
- United States, Kenya, Spain
Portfolio highlights
- Leena AI — Leena AI enhances employee experience via HR helpdesk automation and employee engagement software.
- Racket — Let's make a racket.
- Alpha Tau Medical — Alpha Tau Medical provides highly potent and conformal Alpha Radiotherapy (Alpha DaRT) for solid cancer tumors.
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point.
Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more
Investment focus
- Artificial Intelligence, Machine Learning, Health Care
- Series A, Seed, Series B
- Israel, United States, Switzerland
Portfolio highlights
- Wisdo Health — Our award-winning social health platform utilizes SDOH assessments and pro-social measures to increase quality of life and decrease medical spending.
- WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
- CommonGround-AI — We provide a software solution that delivers the benefits of face to face plus a whole lot more.
Ran Tuttnauer
Show more
Investment focus
- Health Care, Big Data, Medical Device
- Seed, Series A
- Israel, Canada, United States
Portfolio highlights
- Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
- Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
- Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders Geneyx
Entrepreneur at heart. Angel investor in past two decades.
I had the privilege to invest in the following startups, mostly at seed level:
Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens...
But mostly, I am known as Oren from Oren's Hummus :)
Show more
Investment focus
- FinTech, Software, Customer Service
- Seed, Series A, Angel
- United States, Israel
Portfolio highlights
- Openbase — Find and compare the best open-source packages in hundreds of categories - withpowerful metrics and user reviews
- Annabella — The only Breast Pump that simulates your baby's tongue to optimize milk output naturally and efficiently. Our Tongue Technology is known to stimulate milk-producing hormones.
- Annabella Tech — Annabella is the only breast pump in the world with a patented mechanism that replicates the tongue and other inner parts of the baby's mouth. By simulating baby's suckling motion, the pump triggers mothers' natural reflex, allowing more milk to be extracted in less time. Annabella is small, quiet, portable and rechargeable - it canbe used in any place at any time and fit to a small hand bag. It has only two parts that needs to be washed and assembled. It is controlled by an app that records the pumping session and adjusts the pumping plan to fit to the mothers' personal need or suggests a better suited one.
Moshe Yanai has been instrumental in the development of some of the most advanced and successful storage technologies in the history of the industry.
Mr. Yanai began his career in the 1970s, building IBM-compatible mainframe storage based on minicomputer disks. He went on to develop high-end storage systems for Nixdorf, and in the late 1980s,joined EMC, leading the team that developed Symmetrix (today’s “DMX series”). As Vice President of EMC’s Symmetrix group, Mr. Yanai was responsible for design and development of all hardware and software products for EMC’s industry-leading enterprise storage systems. Based in Hopkinton, Massachusetts, EMC’s Symmetrix group grew from only one employee in 1987 to more than 3500 under his leadership.
Mr. Yanai graduated in 1975 from the Technion, Israel Institute of Technology with a Bsc in Electrical Engineering. He holds over 40 patents for various innovative storage hardware and software-related technologies.
Show more
Investment focus
- Artificial Intelligence, Data Storage, Medical
- Seed, Series B, Series D
- Israel, United States
Portfolio highlights
- Infinidat — Infinidat's enterprise storage solutions offer the performance, flexibility and reliability necessary to support today's data intensive enterprises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding.
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Seed, Funding Round, Series B
- Israel, United States
Portfolio highlights
- Laxis — Learn how UX designers, product managers, market research, consultants, and attorneys use conversation Intelligence to supercharge their business and increase revenue. Learn more.
- Deci AI — Deci empowers deep learning developers to accelerate inference on edge or cloud, reach production faster, and maximize hardware potential.
- Velocity — Accelerate the way you build and deliver products. Spin up fully isolated, production-like environments in seconds. Work with your existing dev toolbox.
Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.
Show more
Investment focus
- Health Care, Therapeutics, Medical Device
- Funding Round
- Israel
Portfolio highlights
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Jim Elkind is a private healthcare investor.
Show more
Investment focus
- Medical, Hospital, Health Care
- Series A
- Israel
Portfolio highlights
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Haim Chizic is an individual investor.
Show more
Investment focus
- Medical Device, Clinical Trials, Health Diagnostics
- Seed
- Israel
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Amir Gross is the CEO of Cardiovalve.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Funding Round
- Israel
Portfolio highlights
- BrainQ — BrainQ is developing breakthrough precision neurology therapies using Brain Computer Interface technology....
Benny Levin is a founder and former CEO of NICE.
Show more
Investment focus
- Medical, Hospital, Health Care
- Series A
- Israel
Portfolio highlights
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Avi Kornreich is a former CEO of Agentek.
Show more
Investment focus
- Medical, Hospital, Health Care
- Series A
- Israel
Portfolio highlights
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.
Show more
Investment focus
- Advertising, Association, Social Media Marketing
- Seed, Series A, Convertible Note
- Israel, United States
Portfolio highlights
- Apester — Supercharge your marketing and funnel with interactive content experiences that generate more leads, engage and convert users, and boost retention
- Yoocan — Yoocan is a global community for people with disabilities and their families, discover empowering stories, find support, and connect with a world that understands you.
- IndieFlow — IndieFlow developed a workflow management platform for the music industry. The platform provides a centralized platform to manage music industry workflows and streamline the major building blocks of an artist’s career. It enables users to manage creative projects, distribute to streaming platforms, collect roylaties, register music with royaltycollection societies, promote music, book gigs, receive payments and more.
Jeremy Coller founded the business in 1990.Prior to this, Jeremy spent five years at Imperial Chemical Industries (ICI) Investment Management, where he pioneered the acquisition of private equity secondaries.He began his career as a public equities investment analyst at Fidelity International Investment Management in London.Jeremy holds aBSc (Hons) in Management Sciences from the University of Manchester, UMIST; an MA in Philosophy from Sussex University; and a Diplôme Cours de Civilisation from the Sorbonne. He attended Carmel College.
Show more
Investment focus
- News, Video, Mobile
- Seed, Pre-Seed, Series A
- Israel, United Kingdom
Portfolio highlights
- Castor Technologies — CASTOR is a complete decision support system for utilizing industrial additive manufacturing
- Penfold — Our flexible, simple and powerful pension is designed to get you to your saving goals and stay with you for life, whichever direction it takes you.
- X-trodes — X-trodes is a technology start-up that develops unique wearable, wireless technology, and advanced analytics of biopotential signals.
Shahar is a Managing Partner at TLV Partners I, II, III.
Shahar is a board member in Aidoc, Buildots, Canopy Immuno-Therapeutics, Deepcure, EverAfterAI, Granulate, Guesty, Hunterz, Immunai, Odo, ScyllaDB, Shookit, Silverfort.Before joining TLV Partners Shahar was a General Partner at Magma Venture Partners III and IV and was a board member inAidoc, Applitools, CloudEndure (acquired by Amazon), Coretigo, Guesty, Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, Tonkean
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Series A, Seed, Series B
- Israel, United States
Portfolio highlights
- Aidoc — Aidoc is an Israel-based startup providing artificial intelligence tools for radiologists. Their products help detect and pinpoint critical anomalies for radiologists through deep learning and AI algorithms that analyze medical images and patient data. Aidoc eases up the work list and frees up time and attention to what matters. The startupdeidentifies these and sends them onto Aidoc’s cloud, where algorithms identify and highlight abnormalities before returning the images to radiology workstations for reidentification.Aidoc's s solutions aid radiologists in reducing turnaround time and increasing quality and efficiency by flagging acute anomalies in real-time. It also offers tests for intracranial hemorrhages and spinal fractures, plus several chest exams for pulmonary embolisms, pneumothorax, rib fractures, and lung nodules.Aidoc was founded by Guy Reiner, Elad Walach, and Michael Braginsky in 2016 and is headquartered in Tel Aviv, Israel.
- Buildots — Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project.
- DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.
Show more
Investment focus
- Semiconductor, Hardware, Health Care
- Series A, Seed, Series B
- Israel, United States
Portfolio highlights
- Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
- Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
- Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
Jacques Seguin is the Chairman Of The Board at Emanate Biomedical.
Show more
Investment focus
- Medical, Medical Device, Health Care
- Seed, Pre-Seed, Funding Round
- Israel, Switzerland
Portfolio highlights
- Pi-Cardia — Pi-Cardia. Next Generation Valve Repair. The next frontier of treatment options for structural heart disease that provides a safe, effective, and affordable non-implant-based catheter solutions.
- Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
- CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Zohar Zisapel
Show more
Investment focus
- Cyber Security, Information Technology, Security
- Series A, Seed, Series B
- Israel, United States
Portfolio highlights
- Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
- Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
- Hailo — Hailo have developed the best performing AI processors for edge devices. Our AI accelerator chips are used for Smart City & Homes, machine learning, automotive AI, retail AI and smart factory Industry 4.0 solutions.
Daniel Koss is an individual investor.
Show more
Investment focus
- Medical Device, Clinical Trials, Health Diagnostics
- Seed
- Israel
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.
Show more
Investment focus
- Health Care, Medical, Artificial Intelligence
- Funding Round, Series B, Series C
- Israel, United States
Portfolio highlights
- Treato — Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions.Treato's big data analytics are availablein a consumer site and as an in-depth service for pharmaceutical marketers.Treato's Consumer site (
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Ole T. Jensen
Show more
Investment focus
- Biotechnology, Medical Device
- Funding Round
- Israel
Portfolio highlights
- Nobio — NobioTM developed game-changing technology with the goal to prevent medical device contamination indefinitely, as the first and only fully-integrated anti-biofilm solution. The technology core consists of extremely potent particles which are covered with a high concentration of highly-active anti-microbial structures that kill bacteria uponcontact. The NobioTM particles can be permanently embedded in many products and materials to inhibit formation of biofilm, indefinitely.
Tzachi Arabov is a owner of ACRO.
Show more
Investment focus
- Medical Device, Clinical Trials, Health Diagnostics
- Seed
- Israel
Portfolio highlights
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Rafi Benary is the Co-founder at Innoventric and he holds a Masters’ degree from the New York University in Material Science and a Mechanical Engineering. He is an entrepreneur of 4 start-up companies, bringing them from inception to clinical stage through effective planning and execution.
Show more
Investment focus
- Medical, Medical Device, Health Diagnostics
- Pre-Seed
- Israel
Portfolio highlights
- Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging.
He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.
Show more
Investment focus
- Health Care, Medical Device, Medical
- Series B, Series C, Funding Round
- Israel
Portfolio highlights
- Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
- Serenno Medical —
- RealView Imaging — RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for Augmented Reality applications.
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Sustainability
Agriculture (agtech)
Venture Capital
Restaurants
Publishing
Medical
Email
Wellness
Social Media
Music
Franchise
Celebrity
Android
Internet
Legal
Google
eSports
Construction
Local
Mobile
Enterprise Software
Sports
Social Network
Manufacturing
Digital Media
Facebook
Art
Social Impact
Recruiting
Platforms
Travel
Fitness
Mobile Advertising
Cannabis
Biotechnology
Hospitality
Automotive
Crowdfunding
Wine And Spirits
Medical Device
Social
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Real Estate
Infrastructure
Big Data
Organic Food
Photography
Fashion
Education
B2B
Renewable Energy
Payments
Financial Services
Film
Life Science
Theatre
Sporting Goods
Finance
Retail
Non Profit
SaaS
Software
Cryptocurrency
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Africa
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Bulgaria
Denmark
Algeria
Georgia
Gibraltar
Cameroon
Chile
Kuwait
Israel
Jersey
Kazakhstan
Nicaragua
Philippines
Italy
Mali
Lithuania
Cambodia
Liechtenstein
Kenya
Liberia
Lebanon
Mauritius
Morocco
Malaysia
Norway
Peru
Myanmar
Cayman Islands
Panama
Malta
Mexico
Seychelles
Slovenia
Russian Federation
Rwanda
Serbia
Uzbekistan
Togo
Taiwan
Ukraine
Sierra Leone
Turkey
Tunisia
Thailand
Tajikistan
Poland
Uganda
Zimbabwe
Tanzania
San Marino
Uruguay
Venezuela
Zambia
Senegal
Puerto Rico
Portugal
Sweden
El Salvador
Nigeria
Bahamas
Azerbaijan
Iraq
Iceland
Namibia
United Arab Emirates
Honduras
Finland
Isle of Man
Bolivia
Luxembourg
Estonia
Pakistan
Albania
Faroe Islands
Greece
Ethiopia
Ghana
Hungary
Argentina
Bangladesh
Grenada
Jordan
Romania
Austria
Croatia
Egypt
Belgium
Barbados
Ecuador
France
Hong Kong
Cyprus
Latvia
Oman
Colombia
Switzerland
Guatemala
Marshall Islands
Angel Investors in Israel by industry
Venture Capital
Transportation
Education
Big Data
Finance
Cryptocurrency
Financial Services
Payments
Food and Beverage
Fashion
Art
InsurTech
Medical Device
Wellness
Email
Internet
Social Media
Digital Media
Social Network
Manufacturing
Mobile
Android
Blockchain
Construction
Local
Enterprise Software
Automotive
Sports
Travel
Mobile Advertising
Platforms
Recruiting
Enterprise
Biotechnology
Health Care
Energy
EdTech
Climate
Sustainability
SaaS
Impact
Gaming
Marketplace
Hardware
Real Estate
Retail
Social
Mobile Apps
Infrastructure
B2B
Web3
Medical
Photography
Publishing
Biotech
Music
FinTech
Software
Fitness
Video Games
Proptech
Renewable Energy
Community
Agriculture (agtech)
Consumer
Artificial intelligence
Media (entertainment)
Social Impact